ENDRA Life Sciences
NDRA
12 hedge funds and large institutions have $8.35M invested in ENDRA Life Sciences in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
323% more capital invested
Capital invested by funds: $1.97M → $8.35M (+$6.37M)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
9% more funds holding
Funds holding: 11 → 12 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.15M |
| 2 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
+$1.5M |
| 3 |
Morgan Stanley
New York
|
+$449K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$375K |
| 5 |
5L
55I LLC
Boston,
Massachusetts
|
+$225K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$975K |
| 2 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$449K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$247K |
| 4 |
SC
Saltoro Capital
Dallas,
Texas
|
-$145K |
| 5 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
-$131K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ZCA
26
Zeke Capital Advisors
Berwyn,
Pennsylvania
| – | -$131K | -5 | Closed |
|
27
Renaissance Technologies
New York
| – | -$65K | -2 | Closed |
|
|
WAM
28
Warberg Asset Management
Winnetka,
Illinois
| – | -$15K | -1 | Closed |
|
|
CB
29
CNB Bank
Clearfield,
Pennsylvania
| – | -$4K | – | – |
|
NDRA Hedge Fund Activity: Q1 2021 in Review
12 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2021, worth a combined $8.35M — up 323% from $1.97M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NDRA positions and 6 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.15M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $975K sold.
- 12 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2021, up from 11 in Q4 2020.
- Funds reported $8.35M of ENDRA Life Sciences stock for Q1 2021, up 323% quarter-over-quarter.
- 7 funds opened new ENDRA Life Sciences positions in Q1 2021 and 6 closed out, a net change of +1 holder.
- The largest ENDRA Life Sciences buyer in Q1 2021 was Vanguard Group, an estimated $3.15M added.
- The largest ENDRA Life Sciences seller in Q1 2021 was AIGH Capital Management, an estimated $975K sold.
Based on aggregated 13F filings for Q1 2021.